Sativex and rifampicin
GWCP0602
Phase 1 small_molecule completed
Quick answer
Sativex and rifampicin for Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 is a Phase 1 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed